Tumor Profiling Panel Undergoes Simultaneous FDA, CMS Review
December 9, 2017 12:04 amThe US Food and Drug Administration (FDA) has approved a cancer diagnostic test, FoundationOne CDx (F1CDx, Foundation Medicine), for use in detecting 300-plus genetic mutations in any solid tumor. At the same time, the Centers for Medicare & Medicaid Services … Read more